Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy

Maxine Sun, Firas Abdollah, Marco Bianchi, Quoc Dien Trinh, Shahrokh F. Shariat, Claudio Jeldres, Zhe Tian, Jens Hansen, Alberto Briganti, Markus Graefen, Francesco Montorsi, Paul Perrotte, Pierre I. Karakiewicz

Research output: Contribution to journalArticle

Abstract

Aim of study: To examine the impact of survival probability according to duration of survivorship following radical cystectomy (RC) in patients diagnosed with urothelial carcinoma of the urinary bladder (UCUB). Methods: Overall, 4991 UCUB patients who underwent RC were abstracted. The cumulative survival estimates were used to generate conditional survival rates. Cox regression analyses were performed for prediction of cancer-specific mortality (CSM), according to duration of survivorship. Results: The five-year CSM-free survival rate was 63.9% at RC, and increased to 71.0%, 77.5%, 81.7%, 85.9% and 86.3% in patients who survived ≥1, 2, 3, 4 and 5 years, respectively. Patients with pT2-4 disease benefitted from the highest increase in survivorship two years after RC. The same findings were recorded according to patients' nodal status. Conclusion: The survival of the first two years after RC markedly improves individual patient prognosis. The prognostic gains differ according to patient and tumour characteristics.

Original languageEnglish
Pages (from-to)1503-1511
Number of pages9
JournalEuropean Journal of Cancer
Volume48
Issue number10
DOIs
Publication statusPublished - Jul 2012

Fingerprint

Cystectomy
Urinary Bladder
Carcinoma
Survival
Survival Rate
Neoplasms
Mortality
Regression Analysis

Keywords

  • Conditional survival
  • Radical cystectomy
  • Urothelial carcinoma of the urinary bladder

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Sun, M., Abdollah, F., Bianchi, M., Trinh, Q. D., Shariat, S. F., Jeldres, C., ... Karakiewicz, P. I. (2012). Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy. European Journal of Cancer, 48(10), 1503-1511. https://doi.org/10.1016/j.ejca.2011.11.024

Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy. / Sun, Maxine; Abdollah, Firas; Bianchi, Marco; Trinh, Quoc Dien; Shariat, Shahrokh F.; Jeldres, Claudio; Tian, Zhe; Hansen, Jens; Briganti, Alberto; Graefen, Markus; Montorsi, Francesco; Perrotte, Paul; Karakiewicz, Pierre I.

In: European Journal of Cancer, Vol. 48, No. 10, 07.2012, p. 1503-1511.

Research output: Contribution to journalArticle

Sun, M, Abdollah, F, Bianchi, M, Trinh, QD, Shariat, SF, Jeldres, C, Tian, Z, Hansen, J, Briganti, A, Graefen, M, Montorsi, F, Perrotte, P & Karakiewicz, PI 2012, 'Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy', European Journal of Cancer, vol. 48, no. 10, pp. 1503-1511. https://doi.org/10.1016/j.ejca.2011.11.024
Sun, Maxine ; Abdollah, Firas ; Bianchi, Marco ; Trinh, Quoc Dien ; Shariat, Shahrokh F. ; Jeldres, Claudio ; Tian, Zhe ; Hansen, Jens ; Briganti, Alberto ; Graefen, Markus ; Montorsi, Francesco ; Perrotte, Paul ; Karakiewicz, Pierre I. / Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy. In: European Journal of Cancer. 2012 ; Vol. 48, No. 10. pp. 1503-1511.
@article{05ea1a8a56634421937166e24f41ce28,
title = "Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy",
abstract = "Aim of study: To examine the impact of survival probability according to duration of survivorship following radical cystectomy (RC) in patients diagnosed with urothelial carcinoma of the urinary bladder (UCUB). Methods: Overall, 4991 UCUB patients who underwent RC were abstracted. The cumulative survival estimates were used to generate conditional survival rates. Cox regression analyses were performed for prediction of cancer-specific mortality (CSM), according to duration of survivorship. Results: The five-year CSM-free survival rate was 63.9{\%} at RC, and increased to 71.0{\%}, 77.5{\%}, 81.7{\%}, 85.9{\%} and 86.3{\%} in patients who survived ≥1, 2, 3, 4 and 5 years, respectively. Patients with pT2-4 disease benefitted from the highest increase in survivorship two years after RC. The same findings were recorded according to patients' nodal status. Conclusion: The survival of the first two years after RC markedly improves individual patient prognosis. The prognostic gains differ according to patient and tumour characteristics.",
keywords = "Conditional survival, Radical cystectomy, Urothelial carcinoma of the urinary bladder",
author = "Maxine Sun and Firas Abdollah and Marco Bianchi and Trinh, {Quoc Dien} and Shariat, {Shahrokh F.} and Claudio Jeldres and Zhe Tian and Jens Hansen and Alberto Briganti and Markus Graefen and Francesco Montorsi and Paul Perrotte and Karakiewicz, {Pierre I.}",
year = "2012",
month = "7",
doi = "10.1016/j.ejca.2011.11.024",
language = "English",
volume = "48",
pages = "1503--1511",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "10",

}

TY - JOUR

T1 - Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy

AU - Sun, Maxine

AU - Abdollah, Firas

AU - Bianchi, Marco

AU - Trinh, Quoc Dien

AU - Shariat, Shahrokh F.

AU - Jeldres, Claudio

AU - Tian, Zhe

AU - Hansen, Jens

AU - Briganti, Alberto

AU - Graefen, Markus

AU - Montorsi, Francesco

AU - Perrotte, Paul

AU - Karakiewicz, Pierre I.

PY - 2012/7

Y1 - 2012/7

N2 - Aim of study: To examine the impact of survival probability according to duration of survivorship following radical cystectomy (RC) in patients diagnosed with urothelial carcinoma of the urinary bladder (UCUB). Methods: Overall, 4991 UCUB patients who underwent RC were abstracted. The cumulative survival estimates were used to generate conditional survival rates. Cox regression analyses were performed for prediction of cancer-specific mortality (CSM), according to duration of survivorship. Results: The five-year CSM-free survival rate was 63.9% at RC, and increased to 71.0%, 77.5%, 81.7%, 85.9% and 86.3% in patients who survived ≥1, 2, 3, 4 and 5 years, respectively. Patients with pT2-4 disease benefitted from the highest increase in survivorship two years after RC. The same findings were recorded according to patients' nodal status. Conclusion: The survival of the first two years after RC markedly improves individual patient prognosis. The prognostic gains differ according to patient and tumour characteristics.

AB - Aim of study: To examine the impact of survival probability according to duration of survivorship following radical cystectomy (RC) in patients diagnosed with urothelial carcinoma of the urinary bladder (UCUB). Methods: Overall, 4991 UCUB patients who underwent RC were abstracted. The cumulative survival estimates were used to generate conditional survival rates. Cox regression analyses were performed for prediction of cancer-specific mortality (CSM), according to duration of survivorship. Results: The five-year CSM-free survival rate was 63.9% at RC, and increased to 71.0%, 77.5%, 81.7%, 85.9% and 86.3% in patients who survived ≥1, 2, 3, 4 and 5 years, respectively. Patients with pT2-4 disease benefitted from the highest increase in survivorship two years after RC. The same findings were recorded according to patients' nodal status. Conclusion: The survival of the first two years after RC markedly improves individual patient prognosis. The prognostic gains differ according to patient and tumour characteristics.

KW - Conditional survival

KW - Radical cystectomy

KW - Urothelial carcinoma of the urinary bladder

UR - http://www.scopus.com/inward/record.url?scp=84862016221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862016221&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2011.11.024

DO - 10.1016/j.ejca.2011.11.024

M3 - Article

C2 - 22196034

AN - SCOPUS:84862016221

VL - 48

SP - 1503

EP - 1511

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 10

ER -